Related references
Note: Only part of the references are listed.Anti-TNF-alpha antibody therapies in autoimmune diseases
Kokona Chatzantoni et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
F Atzeni et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity - Biologic and clinical implications in autoimmune arthritis
L De Rycke et al.
ARTHRITIS AND RHEUMATISM (2005)
Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles
PJ Anderson
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints - Extended report
AI Catrina et al.
ARTHRITIS AND RHEUMATISM (2005)
Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study
F Atzeni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Treatment with tumour necrosis factor a antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies
T Jonsdottir et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study
C Ferraro-Peyret et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
F Bobbio-Pallavicini et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn's disease:: A prospective cohort study
S Vermeire et al.
GASTROENTEROLOGY (2003)
Laboratory changes on anti-tumor necrosis factor treatment in rheumatoid arthritis
M Ziolkowska et al.
CURRENT OPINION IN RHEUMATOLOGY (2003)
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
L De Rycke et al.
ARTHRITIS AND RHEUMATISM (2003)
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
F Baert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Infliximab-induced lupus in Crohn's disease: a case report
P Sarzi-Puttini et al.
DIGESTIVE AND LIVER DISEASE (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections
G Ferraccioli et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway
A Lügering et al.
GASTROENTEROLOGY (2001)
Severe inflammatory arthritis and lymphadenopathy in the absence of TNF
IK Campbell et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
The role of nucleosomes in lupus
Z Amoura et al.
CURRENT OPINION IN RHEUMATOLOGY (2000)
The role of CpG motifs in innate immunity
AM Krieg
CURRENT OPINION IN IMMUNOLOGY (2000)
Share Paper
